Pharmaniaga is to open the country's first halal insulin fill and finish facility.
Malaysia's largest listed pharmaceutical company, Pharmaniaga Berhad, is to invest $14 million in a halal insulin facility, slated to open in 2025.
It is a needed move, with no halal certified facility operating in the country, despite rising numbers of diabetics in Malaysia. Worldwide, some 537 million adults (20-79 years) live with diabetes, costing an estimated $966 billion in health expenditure – a 316% increase over the last 15 years, according to the International Diabetes Federation.
Continue reading
Free, in under 30 seconds
Join thousands of professionals reading Salaam Gateway — the Global Islamic Economy Gateway.
Joined by 12,000+ Islamic economy professionals
Create a free account
Already a member? Sign in
- 5 free articles every month
- Weekly Islamic-economy newsletter
- Save articles to read later
